Stanford University
Showing 31-40 of 372 Results
-
Chenjie Pan
Basic Life Research Scientist, Biology
BioI obtained my PhD from Dr. Xiaodong Wang's lab, National Institute of Biological Sciences, Beijing/Tsinghua University. My major work during PhD is on the biochemical mechanism of myelin breakdown. I have expertise in in-tissue immunoprecipitation and pain behavior. Now I am working on axon guidance, degeneration, and plasticity in Dr. Marc Tessier-Lavigne's lab in Department of Biology.
-
Jennifer Pan
Sir Robert Ho Tung Professor of Chinese Studies, Professor of Communication, Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of Political Science and of Sociology
BioJennifer Pan is a political scientist whose research focuses on political communication, digital media, and authoritarian politics. She is the Sir Robert Ho Tung Professor of Chinese Studies, Professor of Communication and (by courtesy) Political Science and Sociology, and a Senior Fellow at the Freeman Spogli Institute.
Dr. Pan's research uses experimental and computational methods with large-scale datasets on political activity to answer questions about the role of digital media in politics, including how political censorship, propaganda, and information manipulation work in the digital age and how preferences and behaviors are shaped as a result. Her work has appeared in peer-reviewed publications such as the American Political Science Review, American Journal of Political Science, Journal of Politics, Science, and Nature.
She graduated from Princeton University, summa cum laude, and received her Ph.D. from Harvard University’s Department of Government. -
Minggui Pan, MD, PhD
Clinical Professor, Medicine - Oncology
BioDr. Pan is a board-certified, fellowship-trained medical oncologist with the Stanford Medicine Cancer Center and a clinical professor in the Department of Medicine, Division of Oncology.
He diagnoses and treats various oncological conditions and specializes in the treatment of bone and soft tissue sarcoma. He creates personalized and comprehensive care plans for each patient he serves.
Dr. Pan’s research focuses include understanding how genomic alterations impact the biological behavior and prognosis of sarcomas. In his work, he identifies new targets for developing innovative therapeutics for sarcoma treatment.
Dr. Pan has more than eighty publications and presented many abstracts in several cancer and immunology conferences. His papers have been published in the Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Nature Review Clinical Oncology, Nature Nanotechnology, Frontier Endocrinology, JCO Oncology Practice, Journal of Hematology and Oncology, British Journal of Cancer Reports, and other peer-reviewed journals. He has also presented to his peers at international, national, and regional meetings, including the annual meetings of American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society for Medical Oncology (ESMO), Chinese Society Of Clinical Oncology (CSCO), Connective Tissue Oncology Society (CTOS) and others.
Dr. Pan is a member of American Society of Clinical Oncology, American Association for Cancer Research, American Association of Immunologists, American Association for Advancement of Science, Society for Immunotherapy of Cancer, and Connective Tissue Oncology Society. Dr. Pan is also an adjunct investigator with Kaiser Permanente Division of Research. -
Danielle Mari Panelli
Instructor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioDr. Danielle Panelli, MD, MS is an Instructor in Maternal–Fetal Medicine in the Department of Obstetrics and Gynecology at Stanford University School of Medicine. She completed Ob/Gyn residency training at Harvard (Brigham and Women’s Hospital/Mass General Hospital), and both fellowship training in Maternal–Fetal Medicine and a Masters Degree in Epidemiology and Clinical Research at Stanford.
Dr. Panelli is a clinician–scientist whose work bridges clinical and translational research to understand how stress and mental health shape pregnancy outcomes and postpartum recovery. Her research program focuses on psychobiologic markers of stress—including telomere dynamics and epigenetic aging—to advance precision medicine approaches for perinatal mental illness and pregnancy complications.
Clinically, she cares for routine and high-risk obstetric patients and integrates trauma-informed, evidence-based approaches into care delivery. She is committed to mentorship and education, serves as Director of Research for the Maternal–Fetal Medicine Fellowship, and contributes to national leadership and scholarship in perinatal mental health.
